Applying the HIV Prevention Cascade to an Evaluation of a Large-Scale Combination HIV Prevention Programme for Adolescent Girls and Young Women in South Africa
- PMID: 37462890
- PMCID: PMC10940416
- DOI: 10.1007/s10461-023-04130-z
Applying the HIV Prevention Cascade to an Evaluation of a Large-Scale Combination HIV Prevention Programme for Adolescent Girls and Young Women in South Africa
Abstract
Adolescent girls and young women (AGYW) in South Africa are at a three times higher risk of acquiring HIV than their male counterparts. The HIV prevention cascade is a tool which can be used to measure coverage of HIV prevention services, although there is limited empirical evidence to demonstrate its application in low-resourced settings. The unifying framework is a conceptualisation of the HIV prevention cascade which theorises that both motivation and access are required for an individual to effectively use an HIV prevention method. We applied this framework to data from a random sample of 127,951 beneficiaries of a combination HIV prevention programme for AGYW aged 15-24 in South Africa to measure the steps to, and identify key barriers to, effective use of male condoms and oral pre-exposure prophylaxis (PrEP) among this vulnerable population. Barriers to each step were analysed using univariate and multivariable logistic regression. Among self-reported HIV-negative AGYW who had sex in the past 6 months, effective use of condoms (15.2%), access to PrEP (39.1%) and use of PrEP (3.8%) were low. AGYW were: less likely to be motivated to use condoms if they believed that they had a faithful partner (aOR 0.44, 95% CI 0.22-0.90) or disliked condoms (aOR 0.26, 95% CI 0.11-0.57), less likely to access condoms if the place where AGYW accessed them was far away (aOR 0.25, 95% CI 0.10-0.64), more likely to effectively use condoms if they received counselling on how to use them (aOR 2.24, 95% CI 1.05-4.76), less likely to be motivated to use PrEP if they did not believe PrEP was efficacious (aOR 0.35, 95% CI 0.17-0.72), more likely to be motivated if they felt confident that they could use PrEP, and more likely to have access to PrEP if they had ever been offered PrEP (aOR 2.94, 95% CI 1.19-7.22). This combination HIV prevention programme and similar programmes should focus on risk-reduction counselling interventions for AGYW and their male partners to improve effective use of condoms and ensure easy access to condoms and PrEP by making them available in youth-friendly spaces. Our findings demonstrate that the application of HIV prevention cascades can inform AGYW HIV prevention programming in low-resourced settings.
Keywords: Adolescent girls and young women; Condoms; HIV prevention cascades; PrEP; South Africa.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures



Similar articles
-
The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.Trials. 2021 Jul 26;22(1):489. doi: 10.1186/s13063-021-05402-6. Trials. 2021. PMID: 34311754 Free PMC article.
-
Using a HIV prevention cascade for identifying missed opportunities in PrEP delivery in Kenya: results from a programmatic surveillance study.J Int AIDS Soc. 2020 Jun;23 Suppl 3(Suppl 3):e25537. doi: 10.1002/jia2.25537. J Int AIDS Soc. 2020. PMID: 32602658 Free PMC article.
-
Barriers to PrEP use and adherence among adolescent girls and young women in Eastern, Southern, and Western Africa: a scoping review.BMC Womens Health. 2024 Dec 26;24(1):665. doi: 10.1186/s12905-024-03516-y. BMC Womens Health. 2024. PMID: 39725977 Free PMC article.
-
Mandrax use, sexual risk, and opportunities for pre-exposure prophylaxis among out-of-school adolescent girls and young women in Cape Town, South Africa.S Afr Med J. 2022 Apr 29;112(5):341-346. S Afr Med J. 2022. PMID: 35587247 Free PMC article.
-
HIV pre-exposure prophylaxis for adolescent girls and young women in Africa: from efficacy trials to delivery.J Int AIDS Soc. 2019 Jul;22 Suppl 4(Suppl Suppl 4):e25298. doi: 10.1002/jia2.25298. J Int AIDS Soc. 2019. PMID: 31328444 Free PMC article. Review.
References
-
- UNAIDS. Understanding Fast-Track Targets. Accelerating action to end the AIDS epidemic by 2030. Unaids. 2021. Available from: https://www.unaids.org/sites/default/files/media_asset/201506_JC2743_Und...
-
- World Health Organisation. Health in 2015: from MDGs, Millennium Development Goals to SDGs, Sustainable Development Goals. Geneva: WHO; 2015. Available from: https://apps.who.int/iris/bitstream/handle/10665/200009/9789241565110_en...
-
- UNAIDS. FACT SHEET 2022—Global HIV statistics. 2022. Available from: https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_...
-
- UNAIDS. South Africa—HIV and AIDS Estimates. UNAIDS. 2021. Available from: https://www.unaids.org/en/regionscountries/countries/southafrica
-
- Simbayi L, Zuma K, Zungu N, Moyo S, Marinda E, Jooste S, et al. South African National HIV Prevalence, Incidence, Behaviour and Communication Survey, 2017. 2018. Available from: https://hsrc.ac.za/uploads/pageContent/10779/SABSSM%20V.pdf
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous